Press release
Insomnia Market Expected to Expand at a Steady CAGR through 2016 - 2026
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases such as cancer at the forefront. The launch of new products such as E-2006 by Eisai Co. Ltd. and Belsomra by Merck & Co. Inc. is forecasted to stimulate the market growth handsomely.
Request Sample Copy of the Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20246
The global insomnia market could be segmented according to over-the-counter (OTC) treatment, non-pharmacological treatments, and pharmacological treatments, where each category is evaluated to contribute their part toward the global growth.
The researchers who have authored this report prioritize painstaking primary and secondary research to compile statistical data and other analytics of the global insomnia market. Players in the market can gain a decisive insight into the guidelines required to extend their portfolio in the right direction and achieve a tangible success in the market.
Global Insomnia Market: Key Trends
With the two premier categorizations of the worldwide insomnia market into play, viz. non-pharmacological treatments and pharmacological treatments, manufacturers can expect lucrative prospects from both the segments. The cognitive behavioral therapy for insomnia (CBTI) listed under non-pharmacological treatments extends the ability of physicians to heal patients or understand their health issues in a comprehensive manner. Such treatments including hypnotherapy can be employed by doctors to take multiple approaches during the treatment of their patients. There are other treatments such as aroma music, bright light, biofeedback, acupuncture, and yoga therapies which could contribute to the growth of the non-pharmacological treatments market.
Likewise, pharmacological treatments are prognosticated to lay a strong platform for the global insomnia market to find more growth prospects on the back of key segments such as OTC sleep aids and prescription sleep aids.
The international insomnia market could go through a downtime period due to inferior diagnosis rate, below par patient compliance, patent erosion, and ascendancy of generic products. Howbeit, the surging incidences of insomnia and unfulfilled medical needs, for instance, the inefficiency of central nervous system (CNS) drugs, are foreseen to compensate for the probable decline in growth.
Global Insomnia Market: Geographical Study
For the most part of the share in world insomnia market, the Americas including North America are foretold to showcase extensive dominance while offering some groundbreaking opportunities for global players. In the U.S., the OTC treatment market is anticipated to register a higher CAGR to address its growth in the insomnia pharmacological treatment sector. The OTC sleep aids market can be classified into valerian roots, melatonin, and antihistamines. An increasing number of patients are convinced to adopt OTC sleep aids because of the infamous side effects caused by prescription drugs and low prices and easy availability of OTC treatments. The U.S. insomnia market is predicted to gain support from the rising consumption of valerian roots and melatonin, owing to their crucial advantages such as decreased stress levels and less side effects.
The Americas could be followed by Europe, the Middle East, and Africa on account of the augmenting interest in spreading health awareness through various programs and inflating geriatric population. The insomnia market in Asia Pacific is also looked upon as a decent opportunity for vendors to capitalize on with the elevating disposable income and upsurge in the occurrence of chronic diseases.
Global Insomnia Market: Top Companies
Some of the prominent companies functioning in the international insomnia market are Purdue Pharma L.P., Pernix Therapeutics, Takeda Pharmaceutical Company Ltd., Sanofi, Pfizer, Inc., Meda Consumer Healthcare Inc., Merck & Co. Inc., and Eisai, Co. Ltd.
Request TOC of the Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=20246
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Market Expected to Expand at a Steady CAGR through 2016 - 2026 here
News-ID: 709294 • Views: …
More Releases from Transparecny Market Research
Global Microgrid Controller Market Forecast 2024-2034 - Market Size, Drivers, Tr …
The global microgrid controller market is witnessing significant growth as decentralized energy systems gain traction. Microgrid controllers, the nerve centers of microgrids, manage distributed energy resources (DERs), ensuring efficient energy distribution, storage, and consumption. These systems provide resilience, optimize costs, and integrate renewable energy sources like solar and wind into the grid seamlessly.
The market is projected to grow at a robust compound annual growth rate CAGR 12.8 from 2024 to…
Lithium Tantalate Crystal Market to hit USD 790 million by 2027, Says Transparen …
The Lithium Tantalate Crystal Market has been witnessing a substantial surge from 2019 to 2027, attributed to its diverse applications across various industries. Lithium Tantalate (LiTaO3) crystals find extensive usage in electronics, telecommunications, and optoelectronics owing to their exceptional piezoelectric and electro-optic properties.
Lithium Tantalate Crystal market is expected to reach a valuation of US$ 790 million by the end of the forecast period, which spans from 2019 to 2027. Additionally,…
North America Climbing Gym Market Size & Share to Surpass USD 1.9 billion by 203 …
The global North America Climbing Gym Market (سوق التسلق في أمريكا الشمالية) has been sailing through robust waters, witnessing a valuation of US$ 947.7 million in 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 8.5% from 2023 to 2031. By the end of 2031, the industry is expected…
Multi-functional Printer Market is expected to grow at 7.2% of CAGR through 2023 …
The global Multi-functional Printer Market (複合機市場) has been sailing through robust waters, witnessing a valuation of US$ 31.2 billion in 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 7.2% from 2023 to 2031. By the end of 2031, the industry is expected to anchor at an impressive US$…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
